• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

weekly epidemiological record June 2 2006

Re: weekly epidemiological record June 2 2006

From the report:

QUOTE

If initial containment is not effective, it is anticipated that
global spread will occur as soon as 3 months after the
emergence of a pandemic virus, with outbreaks reported
from all continents.
By that time, large-scale influenza vaccine
production is likely to have only just started. This scenario
would indicate that influenza vaccines will be available
only to a small minority of countries and their populations.
The current manufacturing capacity for influenza
vaccine is driven by demand for seasonal vaccine
(~300 million doses per year). If the antigen content of a
pandemic vaccine was similar to the seasonal one, and if
the production yields were the same as for seasonal vaccine,
then this would result in 900 million pandemic vaccinations
available per year. It is important to consider that
>65% of world influenza vaccine is produced in Europe
and that 3 companies hold >80% of the manufacturing
capacity. Several technical solutions are to be explored to
shorten the influenza pandemic vaccine gap. However, in
the short and mid-term (up to 5 years), inequitable access
to influenza pandemic vaccines will remain a reality, and a
profound change is unlikely without new vaccines and immunization
approaches. It is important therefore that
countries without access to pandemic vaccines have other
public health control measures in place.

END QUOTE
 
Back
Top